Eip Pharma, Inc. announced it raised $6 Million in an initial filing from an offering of $10 Million

Company

Location

About

EIP Pharma, Inc. is a private, Boston, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. EIP Pharma was launched in 2014 by R&D executives from the pharmaceutical and biotech industry. For more information about the company and updates, please visit www.eippharma.com or follow us on Twitter at @EIP_Pharma.